Litcius/Paper detail

Injectable Hydrogel for NIR-II Photo-Thermal Tumor Therapy and Dihydroartemisinin-Mediated Chemodynamic Therapy

Danyang Chen, Chuang Chen, Chunyu Huang, Tongkai Chen, Zeming Liu

2020Frontiers in Chemistry29 citationsDOIOpen Access PDF

Abstract

In traditional Chinese medicine, dihydroartemisinin (DHA) is the focus of extensive attention because of its unique activity with Fe2+ to produce reactive oxygen species (ROS) and promote apoptosis. In this work, we designed a newfangled ink@hydrogel containing FeCl3, traditional Chinese ink (Hu Kaiwen ink), and agarose hydrogel to create a synergistic activity with DHA in the treatment of cancer. When the system is irradiated under 1064 nm for a few minutes, the ink in the ink@hydrogel converts the light to heat and hyperthermia causes the reversible hydrolysis of hydrogel. Then, Fe3+ quickly diffuses from the hydrogel to the tumor microenvironment and is reduced to Fe2+ to break the endoperoxide bridge in pre-injected DHA, which results in the release of free radicals for a potent anticancer action. To our knowledge, this is the first report of a hydrogel tumor therapy system that induces a photo-thermal response in the second near infrared window (NIR-II). In vivo experiments also showed a significant effect of DHA-Fe2+ in chemodynamic therapy (CDT) and in photo-thermal therapy. This hydrogel platform provided an encouraging idea for synergistic tumor therapy.

Topics & Concepts

DihydroartemisininIn vivoSelf-healing hydrogelsChemistryReactive oxygen speciesCancer therapyTumor microenvironmentSinglet oxygenPhotodynamic therapyBiophysicsCancer researchCancerTumor cellsBiochemistryOxygenMedicinePolymer chemistryOrganic chemistryImmunologyBiologyMalariaBiotechnologyInternal medicinePlasmodium falciparumArtemisininNanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryImmune cells in cancer
Injectable Hydrogel for NIR-II Photo-Thermal Tumor Therapy and Dihydroartemisinin-Mediated Chemodynamic Therapy | Litcius